Grace Therapeutics GRCE
NASDAQ GRCE
$1.92 -0.05 (-2.28%)
As of: Oct 22, 2026 · 12:21 PM EDT

Grace Therapeutics (GRCE) Operating Margin (2020 - 2026)

Updated

Grace Therapeutics (GRCE) reported Operating Margin of -2000.00% for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 424.69 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Operating Margin (2020 - 2026) Analysis & Trends

For FY2021 (ended Mar 31, 2021), Grace Therapeutics posted Operating Margin of -8377.04%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,174.91 Bn 1,143.49 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 644.40 Bn 562.93 Bn 17.26 Bn 28.21%
3 AbbVie 503.86 Bn 476.97 Bn 12.70 Bn 37.86%
4 Merck 379.74 Bn 334.12 Bn 12.21 Bn -3.52%
5 Novartis Ag 303.49 Bn 267.48 Bn 11.24 Bn 32.97%
6 Astrazeneca 269.36 Bn 243.04 Bn 12.86 Bn 20.57%
7 Amgen 243.43 Bn 198.83 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn -133.21%
9 Pfizer 172.94 Bn 119.58 Bn 10.94 Bn 28.37%
10 Grace Therapeutics 33.24 Mn -33.02 Mn - -11,288.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,288.65%
Mar 31, 2026 -2,181.16%
Dec 31, 2025 -1,423.84%
Sep 30, 2025 -1,470.35%
Jun 30, 2025 -1,514.71%
Mar 31, 2025 -1,729.89%
Dec 31, 2024 -2,916.54%
Sep 30, 2024 -2,654.40%
Jun 30, 2024 -2,111.91%
Mar 31, 2021 -2,000.00%
Dec 31, 2020 -2,424.69%
API Access

Grace Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY